Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President, Representative Director: Gyo Sagara, “ONO”) announced that it was continuously selected as constituent of the ESG (Environmental, Social and Governance) investment index provided by MSCI, FTSE Russell, etc.

　ONO has been selected for the “MSCI Japan ESG Select Leaders Index” (MSCI) for the third consecutive year, for the “FTSE4Good Index Series” and the “FTSE Blossom Japan Index” (FTSE Russell) both for the fourth consecutive year, as well as for the “S&P/JPX Carbon Efficient Index” (Tokyo Stock Exchange and S&P Dow Jones Index) for the fourth consecutive year.
　“MSCI Japan ESG Select Leaders Index”, “FTSE Blossom Japan Index” and “S&P/JPX Carbon Efficient Index” are the indices adopted, as references to select ESG investments, by the Japanese Government Pension Investment Fund (GPIF), one of the world’s largest pension funds that manages and invests the reserve funds of the National Pension and the Employees' Pension Insurance.

　Under the corporate philosophy of “Dedicated to the Fight against Disease and Pain”, ONO continues to contribute to the sustainable development of society and enhance sustainable corporate value.

　For details of the ONO ESG initiatives, please refer to the following Sustainability item on our website: （https://sustainability.ono-pharma.com/en ）.